Noah Berkowitz
Vermögen: 2 Mio $ am 31.08.2026
Vermögen: 2 Mio $ am 31.08.2026
Noah Berkowitz is the founder of Physician's Choice, Inc. Currently, Dr. Berkowitz is President & Chief Executive Officer at HaptoGuard, Inc. Formerly, Dr. Berkowitz was Chief Medical Officer at Arvinas, Inc. from 2024 to 2026, President, Chief Executive Officer & Secretary at Synvista Therapeutics, Inc. from 2006 to 2012, Director at Poseida Therapeutics, Inc., Vice President-Clinical Development at IMPATH, Inc., Consultant at Predix Pharmaceuticals, Inc., Consultant at Teva Pharmaceuticals USA, Inc., and Senior Vice President & Head-Hematology at Bristol Myers Squibb Co. Education includes undergraduate and doctorate degrees from The Trustees of Columbia University in The City of New York.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARVINAS, INC. 0,29 % | 11.05.2026 | 191.395 ( 0,29 % ) | 2 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
HaptoGuard, Inc.
HaptoGuard, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Vorstandsvorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ARVINAS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 03.07.2026 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| POSEIDA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
IMPATH, Inc.
IMPATH, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory services | Technik-/Wissenschafts-/F&E-Leiter | - |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Synvista Therapeutics, Inc.
Synvista Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases of cardiovascular aging and diabetes complications | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
IMPATH, Inc.
IMPATH, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory services | Health Services |
HaptoGuard, Inc.
HaptoGuard, Inc. BiotechnologyHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Health Technology |
Predix Pharmaceuticals, Inc.
Predix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Developes novel drugs and other related products | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Physician's Choice, Inc.
Physician's Choice, Inc. Internet Software/ServicesTechnology Services Provides postclinical, premarketing, cost-benefit analysis to biotech companies | Technology Services |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen